Details for New Drug Application (NDA): 201676
✉ Email this page to a colleague
The generic ingredient in SIROLIMUS is sirolimus. There are twenty-one drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the sirolimus profile page.
Summary for 201676
| Tradename: | SIROLIMUS |
| Applicant: | Zydus Pharms |
| Ingredient: | sirolimus |
| Patents: | 0 |
Pharmacology for NDA: 201676
| Mechanism of Action | Protein Kinase Inhibitors mTOR Inhibitors |
| Physiological Effect | Decreased Immunologic Activity |
Medical Subject Heading (MeSH) Categories for 201676
Suppliers and Packaging for NDA: 201676
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SIROLIMUS | sirolimus | TABLET;ORAL | 201676 | ANDA | Zydus Lifesciences Limited | 65841-771 | 65841-771-01 | 100 TABLET, FILM COATED in 1 BOTTLE (65841-771-01) |
| SIROLIMUS | sirolimus | TABLET;ORAL | 201676 | ANDA | Zydus Lifesciences Limited | 65841-771 | 65841-771-05 | 500 TABLET, FILM COATED in 1 BOTTLE (65841-771-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Feb 15, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Feb 15, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Jan 8, 2014 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
